Gastrointestinal Stromal Tumor
Surgical Oncology Clinics of North America · 2022-07 · 31 (3) · 431-446
DOI: 10.1016/j.soc.2022.03.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2022-07. Verfasst von Ashwyn K Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, CA, USA; Moores Cancer Center, University of Cal…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gastrointestinal Stromal Tumors. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, FDA HHS.
Abstract (Originalsprache)
Over the past 20 years, gastrointestinal stromal tumor (GIST) has evolved into an increasingly complex clinical entity with ever more challenges. While surgical resection is the gold standard, advancements in genetic testing, therapeutic options, immunotherapy, and management of metastatic disease necessitate a comprehensive, multimodal approach for these tumors. This chapter highlights the importance of genomic testing of GIST, the use of neoadjuvant and adjuvant therapy for localized disease, surgical principles for GIST, as well as current and new approaches for addressing metastatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Surgical Oncology, University of California San Diego, San Diego, CA, USA; Moores Cancer Center, University of California San Diego School of Medicine, 3855 Health Sciences Drive, Box…
- Department of Surgery, University of Washington, 1959 NE Pacific Street, Box 356410, Seattle, WA 98195, USA.
- Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen Hufelandstr. 55, Essen 45122, Germany; DKTK Partner Site Essen, German Cancer Consortium (DKTK), Heidelberg, Germany.
Förderung
- NCI NIH HHS
- FDA HHS
Zitieren
APA
Sharma, A. K., Kim, T. S., Bauer, S., & Sicklick, J. K. (2022). Gastrointestinal Stromal Tumor. Surgical Oncology Clinics of North America, 31(3), 431-446. https://doi.org/10.1016/j.soc.2022.03.007
Vancouver
Sharma AK, Kim TS, Bauer S, Sicklick JK. Gastrointestinal Stromal Tumor. Surgical Oncology Clinics of North America. 2022;31(3):431-446. doi:10.1016/j.soc.2022.03.007
BibTeX
@article{Sharma2022,
author = {Sharma, Ashwyn K and Kim, Teresa S and Bauer, Sebastian and Sicklick, Jason K},
title = {Gastrointestinal Stromal Tumor},
journal = {Surgical Oncology Clinics of North America},
year = {2022},
volume = {31},
number = {3},
pages = {431--446},
doi = {10.1016/j.soc.2022.03.007}
}
EUVIMED